GuardIVa® Antimicrobial Hemostatic IV Dressing

The CDC Guidelines recommend the use of a chlorhexidine-impregnated sponge dressing for temporary short term catheters when adherence to basic preventative measures has been unsuccessful.1, 2

1 Warnings: Do not use the GuardIVa® dressing on patients with a known sensitivity to chlorhexidine gluconate. The use of chlorhexidine gluconate containing products has been reported to cause irritation, sensitization, and generalized allergic reactions. If any such reactions occur, discontinue use of the dressing immediately, and if severe, contact a physician.

2 CDC Guidelines, 2011, pg 14. Category 1B

Features

GuardIVa® Arm

GuardIVa® Antimicrobial Hemostatic IV Dressing is an IV site care solution that combines the antimicrobial protection of chlorhexidine gluconate (CHG), a well-known antiseptic agent with broad spectrum antimicrobial and antifungal activity, with the proprietary hemostatic agent which controls surface bleeding from percutaneous catheters and vascular access sites.

Hemostasis

Hemostasis

An in vivo animal test showed that, compared to gauze dressings, wounds treated with the GuardIVa® Dressing significantly reduced time to hemostasis and had up to 7 times less blood loss.1

Healing

An in vivo animal study showed that wounds treated with the GuardIVa® Dressing healed at a rate comparable to untreated wounds, unlike BioPatch™.1


Healing chart

Antimicrobial

Demonstrated in vitro antimicrobial efficacy against test organisms known to cause CRBSIs.1

In vitro testing demonstrated sustained antimicrobial efficacy for up to 7 days. A greater than 4 log reduction in microbial count was observed for all test organisms.

The GuardIVa® dressing has not been clinically tested for its ability to reduce catheter-related blood stream infections.

Antimicrobial organisms

INDICATIONS FOR USE:

The GuardIVa® Antimicrobial Hemostatic IV Dressing is intended for use as a hydrophilic wound dressing to absorb exudate, cover and protect catheter sites. Common applications include IV catheters, other intravenous catheters and percutaneous devices. It is also indicated for control of surface bleeding from percutaneous catheters and vascular access sites.

WARNINGS:

Do not use the GuardIVa® dressing on patients with a known sensitivity to chlorhexidine gluconate. The use of chlorhexidine gluconate containing products has been reported to cause irritation, sensitization, and generalized allergic reactions. If any such reactions occur, discontinue use of the dressing immediately, and if severe, contact a physician.

For external use only. Do not allow this product to contact ears, eyes, mouth or mucous membranes.

PRECAUTION:

GuardIVa® dressing is not intended to treat infection.

1Data on file. Bard Access Systems, Inc., Salt Lake City, Utah. Results may not correlate to clinical performance.

Please consult product labels, IFU, and package inserts for any indications, contraindications, hazards, warnings, cautions, and instructions for use.

Specifications

Code Disk Diameter Hole Diameter Quantity Per Case
FP-22-AD004 1” (2.5 cm) 1.5 mm 10/Box • 10 boxes/case
FP-23-AD008 1” (2.5 cm)/ 4.0 mm 10/Box • 10 boxes/case
FP-24-AD012 1” (2.5 cm)/ 7.0 mm 10/Box • 10 boxes/case

Videos